Quarterly Result13 Aug 2025, 09:22 pm
Samrat Pharmachem Ltd. Reports Q1 FY2025 Financial Results with 10.6% YoY Revenue Growth
AI Summary
Samrat Pharmachem Ltd., a leading manufacturer and exporter of pharmaceutical chemicals, has reported its un-audited financial results for the quarter ended on June 30, 2025. The company's revenue from operations stands at INR 7,565.16 lakhs, representing a 10.6% year-over-year growth. The total income for the quarter is INR 7,634.29 lakhs, while the profit before tax before exceptional items stands at INR 20.78 lakhs.
Key Highlights
- Samrat Pharmachem's Q1 FY2025 revenue from operations stands at INR 7,565.16 lakhs, a 10.6% YoY growth.
- The total income for the quarter is INR 7,634.29 lakhs.
- The profit before tax before exceptional items is INR 20.78 lakhs.
- The company's profit for the year is INR 206.55 lakhs, and the basic and diluted earnings per equity share is INR 6.69.
- The figures for the previous period have been regrouped where necessary to conform to the current period's classification.